Optimum Patient Care

Social Enterprise that provides Medical Research and Services focused on improving the Diagnosis, Treatment and Care of Chronic Disease.

[Optimum Patient Care @OPCare]

New RESA e-tool enables personalised prediction of severe asthma attacks, supporting clinicians with data-driven decisions

Full Publication: https://t.co/FPctTjRgOi
Press Release: https://t.co/R0CmguWeMw

[Optimum Patient Care @OPCare]

New ISAR data shows Greek patients with severe asthma have fewer exacerbations and steroid-related diseases vs global rates, while highlighting key opportunities to enhance patient care

Full Publication: https://t.co/WqQrOSjvZE
Press Release: https://t.co/QLtZwE0juD

[Optimum Patient Care @OPCare]

On #WorldAsthmaDay 2026, we’re highlighting the importance of better asthma care for all.

Read our latest blog:
https://t.co/IG7xUj3eQ4

#WorldAsthmaDay #AsthmaAwareness #RespiratoryHealth #SevereAsthma #ISAR #RealWorldData #OPC

[Optimum Patient Care @OPCare]

ISAR Study: Real-world data and RCTs share common downstream pathways (IgE→BEC, prior attacks) predicting severe asthma exacerbations, while real-world data reveal broader upstream pathways for risk modification
Press: https://t.co/lGDod1qKOV
Publication: https://t.co/5qwpNZykxC

[Optimum Patient Care @OPCare]

New study shows Mexican severe asthma patients use fewer long-term steroids and have fewer related conditions, but higher exacerbations and poorer control highlighting need for earlier, targeted care.

Press release: https://t.co/3b3udgis31
Full article : https://t.co/rHJopgz4nU

[OPRI @OPRI_SG]

OPRI led real-world study with @hospital_hvn @FacMedicinaUGR suggests GLP-1 RAs may cut COPD exacerbations & steroid use, a new insight for complex cardiometabolic care.
Press Release: https://t.co/IejQxq0vXM
Full Article: https://t.co/Aiw3nKFDpx
#COPD #Obesity #GLP1RA #OPCRD

[OPRI @OPRI_SG]

A new study from OPRI demonstrates that long-term cardiovascular and respiratory risks can be predicted in people with COPD using routinely collected primary care data.
Press release: https://t.co/fiLqyzPrLr
Full article : https://t.co/BspHS5Wgjc
#COPD #CardioRespiratory #OPCRD

[Optimum Patient Care @OPCare]

New Australian real-world research shows that a quality-improvement program (ACAER) in primary care significantly reduces asthma and COPD exacerbations.

Press Release: https://t.co/51wDnuCZGO

Full Article: https://t.co/KTGJXBGgPX

#OPCRDA #PrimaryCare #Asthma #COPD

[Optimum Patient Care @OPCare]

Real-world EMBER study shows T2 biologics improve outcomes across all asthma clusters, incl. T2-low, but better treatments still needed.

Full Publication: https://t.co/APDUrvNPti
Press Release: https://t.co/phICXA2q3M

#SevereAsthma #Biologics #Biomarkers #ISAR

[Optimum Patient Care @OPCare]

Title: Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis.⁣
Yadav C P 𝘦𝘵 𝘢𝘭.

Article: https://t.co/GyomMdMfww
Press Release: https://t.co/ZvUNwqdy5Q

#PredictionPathway #ISAR

[Optimum Patient Care @OPCare]

𝐒𝐓𝐀𝐑 𝐬𝐭𝐮𝐝𝐲: Disease burden was high in severe asthma patients using 𝐋𝐓𝐎𝐂𝐒, irrespective of 𝐁𝐄𝐂.⁣
𝘚𝘤𝘩𝘭𝘦𝘪𝘤𝘩 𝘍 𝘦𝘵 𝘢𝘭.
Article: https://t.co/JyO66EgkOB
Press Release: https://t.co/1svXIIFsjQ
Open access license: https://t.co/ox0LAVvC4x
#STARstudy #ISAR

[Optimum Patient Care @OPCare]

Powerful real-world evidence on severe asthma patients:
SOLAR II: Biologics prevent systemic complications of steroid use.
Full article:https://t.co/a3ayBHVFPb
Press release: https://t.co/muDVVotWAy

#SevereAsthma #Biologics #OralCorticosteroids #Research

[Optimum Patient Care @OPCare]

Powerful real-world evidence on severe asthma patients:
SOLAR I: Biologics minimize steroid exposure.
Full article: https://t.co/zJ9LZGgWT5
Press release: https://t.co/sdPxxBMnVr

#SevereAsthma #Biologics #OralCorticosteroids #Research

[Optimum Patient Care @OPCare]

SOLAR II study highlights a major breakthrough in asthma care! Biologics show promise in preventing diabetes, MACE, and other OCS-related adverse outcomes. A game-changer in respiratory treatment!📖Read the full article: https://t.co/HCJeLcpttN #Asthma #Biologics #SOLARII

[Optimum Patient Care @OPCare]

We're excited to be among 19 organizations supported by Health Data Research UK to adopt the #UKHealthDataResearchAlliance Transparency Standards. This helps us enhance access to our work with OPCRD for researchers and the public. #TransparentDataAccess
https://t.co/CBksZsKzqm

[Health Data Research UK (HDR UK) @HDR_UK]

🤔 How well is information on data access processes shared with the public?

Our Public Advisory Board reviewed 70 #UKHealthDataResearchAlliance members’ websites to recommend ways to improve #TransparentDataAccess.

Read Alan’s blog post to learn more ⬇️
https://t.co/pVowKEvWHt

[Optimum Patient Care @OPCare]

We’re celebrating @HDR_UK‘s Transparency Impact Week!
We were thrilled to receive @The_MRC funding to adopt the Alliance Transparency Standards and improve #TransparentDataAccess for healthcare innovation.
Explore the Standards: https://t.co/EvLeFgceHE

[Optimum Patient Care @OPCare]

Great to see our friends at @mendelian_co presenting some of the brilliant work they've been doing in the field of DiGeorge Syndrome at @HealthAIData Conference, using OPCRD data.

Learn more about OPCRD here:
https://t.co/5dEUawbU5A
#AIDATA23 #ResearchInRealLife

[Optimum Patient Care @OPCare]

Senior Epidemiologist, Ghislaine Scelo, recently presented at the DSAR Annual Meeting in Copenhagen, sharing more on the ISAR initiative and latest research highlights.

Learn more about ISAR here:
https://t.co/30WfCzd4AS
#ResearchInRealLife #SevereAsthma #Research

[Optimum Patient Care @OPCare]

We're thrilled to introduce Alexandar Sterling as our new Medical Scientist!

Looking for opportunities in the healthcare and research industry? Take a look at our current job listings here:
https://t.co/CS6aVMD1rg
#MeetTheTeamMonday #MeetTheTeam #ResearchInRealLife #OPCUK